Rachael Morton

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	16799	12013
h-endeksi	60	49
i10-endeksi	169	153

2800

1400

700

2100

20112012201320142015201620172018201920202021202220232024202574 115 204 262 360 470 683 946 1359 1891 2174 2367 2237 2730 594

Genel erişim

Tümünü görüntüle

151 makale

34 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Angela C WebsterUniversity of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Kirsten HowardSchool of Public Health, University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Anne CustThe Daffodil Centre and Melanoma Institute Australia, The University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Graham MannCollege of Health and Medicine, Australian National Universityanu.edu.au üzerinde doğrulanmış e-posta adresine sahip
John F ThompsonMelanoma Institute Australiamelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
Mbathio DiengThe University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Melanie WyldUniversity of Sydney, Westmead Hospitalhealth.nsw.gov.au üzerinde doğrulanmış e-posta adresine sahip
Fliss MurtaghHull York Medical School, University of Hullhyms.ac.uk üzerinde doğrulanmış e-posta adresine sahip
Phyllis Butowsydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Anh Dam TranNational Drug and Alcohol Research Centreunsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Karan Ketan ShahNational Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University ofsydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Rachael C WalkerUniversity of Aucklandauckland.ac.nz üzerinde doğrulanmış e-posta adresine sahip
Robyn SawMelanoma Institute Australiamelanoma.org.au üzerinde doğrulanmış e-posta adresine sahip
Martin StocklerNHMRC Clinical Trials Centre, University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Nadine KasparianUNSWunsw.edu.au üzerinde doğrulanmış e-posta adresine sahip
Patrick KellyAssociate Professor (Biostatistics), The University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip
Kevin PottieResearch Chair, Professor of Family Medicine, Dalhousie Universityuwo.ca üzerinde doğrulanmış e-posta adresine sahip
Steven ChadbanProfessor of Renal Medicine, University of Sydneysswahs.nsw.gov.au üzerinde doğrulanmış e-posta adresine sahip
Jonathan C Craig, Jonathan CraigCollege of Medicine and Public Health, Flinders Universityflinders.edu.au üzerinde doğrulanmış e-posta adresine sahip
Katy BellSchool of Public Health, University of Sydneysydney.edu.au üzerinde doğrulanmış e-posta adresine sahip

Takip et

Rachael Morton

University of Sydney

ctc.usyd.edu.au üzerinde doğrulanmış e-posta adresine sahip

health economics clinical trials melanoma kidney disease patient reported outcomes


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
Chronic kidney disease AC Webster, EV Nagler, RL Morton, P Masson The lancet 389 (10075), 1238-1252, 2017	4516	2017
The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies RL Morton, A Tong, K Howard, P Snelling, AC Webster BmJ 340, 2010	657	2010
A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments M Wyld, RL Morton, A Hayen, K Howard, AC Webster Public Library of Science 9 (9), e1001307, 2012	613	2012
Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care SN Davison, A Levin, AH Moss, V Jha, EA Brown, F Brennan, ... Kidney international 88 (3), 447-459, 2015	590	2015
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CT Chan, PJ Blankestijn, LM Dember, M Gallieni, DCH Harris, CE Lok, ... Kidney international 96 (1), 37-47, 2019	402	2019
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action R Vanholder, L Annemans, E Brown, R Gansevoort, JJ Gout-Zwart, ... Nature Reviews Nephrology 13 (7), 393-409, 2017	328	2017
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease RL Morton, P Snelling, AC Webster, J Rose, R Masterson, DW Johnson, ... Cmaj 184 (5), E277-E283, 2012	256	2012
Establishing core outcome domains in hemodialysis: report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) consensus workshop A Tong, B Manns, B Hemmelgarn, DC Wheeler, N Evangelidis, P Tugwell, ... American Journal of Kidney Diseases 69 (1), 97-107, 2017	214	2017
Cognitive and motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis SL Yeoh, J Eastwood, IM Wright, R Morton, E Melhuish, M Ward, JL Oei JAMA network open 2 (7), e197025-e197025, 2019	205	2019
Patient and caregiver perspectives on home hemodialysis: a systematic review RC Walker, CS Hanson, SC Palmer, K Howard, RL Morton, MR Marshall, ... American Journal of Kidney Diseases 65 (3), 451-463, 2015	203	2015
Increasing access to integrated ESKD care as part of universal health coverage DCH Harris, SJ Davies, FO Finkelstein, V Jha, JA Donner, G Abraham, ... Kidney international 95 (4), S1-S33, 2019	199	2019
Clinical practice guidelines for identification, screening and follow‐up of individuals at high risk of primary cutaneous melanoma: a systematic review CG Watts, M Dieng, RL Morton, GJ Mann, SW Menzies, AE Cust British Journal of Dermatology 172 (1), 33-47, 2015	185	2015
How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting K Breckenridge, HL Bekker, E Gibbons, SN van der Veer, D Abbott, ... Nephrology Dialysis Transplantation 30 (10), 1605-1614, 2015	177	2015
Supportive care: comprehensive conservative care in end-stage kidney disease FEM Murtagh, A Burns, O Moranne, RL Morton, S Naicker Clinical Journal of the American Society of Nephrology 11 (10), 1909-1914, 2016	172	2016
Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study RL Morton, P Snelling, AC Webster, J Rose, R Masterson, DW Johnson, ... American journal of kidney diseases 60 (1), 102-111, 2012	152	2012
Oral THC: CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial P Grimison, A Mersiades, A Kirby, N Lintzeris, R Morton, P Haber, I Olver, ... Annals of Oncology 31 (11), 1553-1560, 2020	151	2020
Social dancing and incidence of falls in older adults: a cluster randomised controlled trial D Merom, E Mathieu, E Cerin, RL Morton, JM Simpson, C Rissel, ... PLoS medicine 13 (8), e1002112, 2016	149	2016
Patient and caregiver values, beliefs and experiences when considering home dialysis as a treatment option: a semi-structured interview study RC Walker, K Howard, RL Morton, SC Palmer, MR Marshall, A Tong Nephrology Dialysis Transplantation 31 (1), 133-141, 2016	148	2016
Characteristics of dialysis important to patients and family caregivers: a mixed methods approach RL Morton, A Tong, AC Webster, P Snelling, K Howard Nephrology Dialysis Transplantation 26 (12), 4038-4046, 2011	140	2011
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review RL Morton, I Schlackow, B Mihaylova, ND Staplin, A Gray, A Cass Nephrology Dialysis Transplantation 31 (1), 46-56, 2016	139	2016

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar